Press Release   -

Ovulation Test Kit Market to Reach USD 6.42 Billion by 2035

According to analysts at Vantage Market Research, the Global Ovulation Test Kit Market size is worth USD 3.13 Billion in 2024 and is projected to reach USD 6.42 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 6.75% from 2025 to 2035. Key trends of market include increasing demand for digital ovulation kits, smartphone-connected devices, rising preference for home testing, e-commerce growth, AI-based fertility tracking, affordability improvements, and expanding adoption in emerging markets.

Market Overview

The growth of the ovulation test kit market is driven by several factors, including the rising prevalence of polycystic ovary syndrome (PCOS) and other hormonal disorders that impact women of reproductive age. Additionally, increasing first-time pregnancy age, declining global fertility rates, and advancements in reproductive technology are contributing to the market expansion. A significant factor boosting demand is the growing awareness of in vitro fertilization (IVF) procedures and their increasing success rates, which have encouraged more women to track their ovulation cycles.

The widespread prevalence of PCOS has also been a key factor in ovulation test kit market growth, as the condition often results in irregular ovulation. Women experiencing fertility challenges—particularly those with PCOS—are increasingly turning to ovulation testing to enhance their chances of conception. According to WHO data from June 2023, 8% to 13% of women of reproductive age worldwide are affected by PCOS, with up to 70% of cases remaining undiagnosed, underscoring the need for accessible fertility monitoring solutions.

Quest and Proov Partner to Expand Access to Home Fertility Testing

• In July 2023, Quest collaborated with Proov to expand access to the home fertility test ‘Proov Confirm PdG,’ making it available through questhealth.com

Key Takeaways from the Report

• North America dominated the market industry with 37.5% of market share in 2024. In Region, market is driven by the increasing demand for advanced ovulation test kits, particularly those featuring Bluetooth connectivity and smart countdown functions
• Based on the Product Type, the Urine-based Ovulation Test Kits category accounted for significant market share of 46.6% in 2024. The Segment is propelled by the high accuracy of these tests in detecting human chorionic gonadotropin (hCG), a key hormone that indicates pregnancy
• In 2024, by Distribution Channel, Pharmacies & Drugstores dominated the market with significant market share of 37.5%. The Segment is driven by the rising number of retail pharmacies in key markets such as Brazil, India, and China
• By End-User, Hospitals dominated the market with market share of 28.7% in 2024. Hospitals are one-stop shops for women in need of fertility help, acting as complete reproductive health institutions

Top Companies

• Piramal Healthcare
• Easy@Home Fertility
• Fairhaven Health
• Proov
• Wondfo
• PREGMATE
• Swiss Precision Diagnostics GmbH
• Accuquik
• Runbio Biotech Co. Ltd.

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Wisp Launches Fertility Vertical to Enhance Pregnancy Planning

• In July 2024, Wisp, a U.S.-based reproductive telehealth provider, announced the launch of its fertility vertical, offering a range of services and products to support women through pregnancy planning

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.